ToolGen Incorporated (KOSDAQ: 199800)

Market Cap	329.29B
Revenue (ttm)	1.07B
Net Income (ttm)	-46.64B
Shares Out	7.94M
EPS (ttm)	-5,885.85
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,387
Open	46,000
Previous Close	46,550
Day's Range	44,700 - 46,550
52-Week Range	44,700 - 110,000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About ToolGen

ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1999
• Employees: 81
• Stock Exchange: KOSDAQ
• Ticker Symbol: 199800

Financial Performance

In 2023, ToolGen's revenue was 1.10 billion, an increase of 48.41% compared to the previous year's 743.46 million. Losses were -42.34 billion, 132.9% more than in 2022.